NF‐κB is a transcription factor that plays a vital regulatory role in the inflammatory and immune pathways, and its activation results in the progression of steatosis to NASH (Malaguarnera et al. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.